Publications of Thomas A. Gardner - IUSM ReSEARCH Connect

96 Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

Jump to:

Books
Book Chapters
Conference Proceedings
Meeting Abstracts
Presentations
Technical Reports
Other Written Works

96 Publications From Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2012

Thomas A. Gardner; Bennett D. Elzey; Noah M. Hahn

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Human Vaccines and Immunotherapeutics. 2012;8(4):526-531.

0
2.
2012

Thomas A Gardner; Bennett D Elzey; Noah M Hahn

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer.
Human vaccines & immunotherapeutics. 2012;8(4):534-539.

2
3.
2011

Bert S. Ivey; Steven M. Lucas; Carl A. Meyer; Tyler E. Emley; Aaron Bey; Thomas A. Gardner; Chandru P. Sundaram

Conversions in laparoscopic renal surgery: Causes and outcomes
Journal of Endourology. 2011;25(7):1167-1173.

2
4.
2011

Thomas A. Gardner; Temel Tirkes; Matthew Mellon; Michael O. Koch

Imaging Techniques for the Patient With Renal Cell Carcinoma
Seminars in Nephrology. 2011;31(3):245-253.

0
5.
2011

Steven M. Lucas; David A. Gilley; Shreyas S. Joshi; Thomas A. Gardner; Chandru P. Sundaram

Robotics training program: Evaluation of the satisfaction and the factors that influence success of skills training in a resident robotics curriculum
Journal of Endourology. 2011;25(10):1669-1674.

0
6.
2010

J.A. Jiménez; X. Li; Y.-P. Zhang; K.H. Bae; Y. Mohammadi; P. Pandya; C. Kao; T.A. Gardner

Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL
Cancer Gene Therapy. 2010;17(3):180-191.

4
7.
2010

Clint D. Bahler; Richard S. Foster; Richard Bihrle; Stephen D.W. Beck; Thomas A. Gardner; Chandru P. Sundaram; Timothy A. Masterson; Liang Cheng; Michael O. Koch

Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer
BJU International. 2010;105(10):1372-1376.

1
8.
2010

Anjana Ganeshappa; Chandru Sundaram; Michelle A. Lerner; Thomas A. Gardner

Role of the laparoscopic approach to cytoreductive nephrectomy in metastatic renal-cell carcinoma: Does size matter?
Journal of Endourology. 2010;24(8):1289-1292.

1
9.
2010

Michelle Boger; Steven M. Lucas; Sara C. Popp; Thomas A. Gardner; Chandru P. Sundaram

Comparison of robot-assisted nephrectomy with laparoscopic and hand-assisted laparoscopic nephrectomy
Journal of the Society of Laparoendoscopic Surgeons. 2010;14(3):374-380.

3
10.
2009

M. Ahn; S.-J. Lee; X. Li; J.A. Jiménez; Y.-P. Zhang; K.-H. Bae; Y. Mohammadi; C. Kao; T.A. Gardner

Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter
Cancer Gene Therapy. 2009;16(1):73-82.

22
11.
2009

Thomas A. Gardner; Sang-Jin Lee; Sang-Don Lee; Xiong Li; Toshihiro Shirakawa; Dong Deuk Kwon; Ra Young Park; Kyu Youn Ahn; Chaeyong Jung

Differential expression of osteocalcin during the metastatic progression of prostate cancer
Oncology Reports. 2009;21(4):903-908.

2
12.
2009

Thomas A. Gardner; Theodore Logan

Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma
Journal of Urology. 2009;182(2):425-426.

0
13.
2008

Matthew J. Mellon; Miwon Ahn; Juan A. Jiménez; Chinghai Kao; Thomas A. Gardner

Anti-angiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse model
Journal of Urology. 2008;179(2):737-742.

4
14.
2008

Xiong Li; You-Hong Liu; Sang-Jin Lee; Thomas A. Gardner; Meei-Huey Jeng; Chinghai Kao

Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy
Clinical Cancer Research. 2008;14(1):291-299.

21
15.
2008

Matthew J. Mellon; Kyung-Hee Bae; Catherine E. Steding; Juan A. Jiménez; Chinghai Kao; Thomas A. Gardner

Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapy
Human Gene Therapy. 2008;19(5):487-495.

2
16.
2007

P.H. Abbosh; X. Li; L. Li; T.A. Gardner; C. Kao; K.P. Nephew

A conditionally replicative, Wnt/Β-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer
Cancer Gene Therapy. 2007;14(4):399-408.

12
17.
2007

Xiong Li; You-Hong Liu; Yan-Ping Zhang; Shaobo Zhang; Xinzhu Pu; Thomas A. Gardner; Meei-Huey Jeng; Chinghai Kao

Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy
Clinical Cancer Research. 2007;13(18):5463-5473.

12
18.
2007

Michael O. Koch; Thomas Gardner; Liang Cheng; Russell J. Fedewa; Ralf Seip; Narendra T. Sangvhi

Phase I/II Trial of High Intensity Focused Ultrasound for the Treatment of Previously Untreated Localized Prostate Cancer
Journal of Urology. 2007;178(6):2366-2371.

15
19.
2007

Toshiro Shirakawa; Shuji Terao; Nobuyuki Hinata; Kazushi Tanaka; Atsushi Takenaka; Isao Hara; Kazuro Sugimura; Masafumi Matsuo; Katsuyuki Hamada; et al.

Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer
Human Gene Therapy. 2007;18(12):1225-1232.

23
20.
2006

Russell J. Fedewa; Roy F. Carlson; Ralf Seip; Narendra T. Sanghvi; M.O. Koch; T.A. Gardner

Prediction of success for HIFU treatments of prostate cancer based on acoustic energy density
Proceedings - IEEE Ultrasonics Symposium. 2006;1:732-735.

1
21.
2006

Xiong Li; Sudhanshu P. Raikwar; You-Hong Liu; Sang-Jin Lee; Yan-Ping Zhang; Shaobo Zhang; Liang Cheng; Sang-Don Lee; Beth Elisa Juliar; Thomas A. Gardner; et al.

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene
Molecular Cancer Therapeutics. 2006;5(3):676-684.

12
22.
2006

Pratik Desai; Juan A. Jiménez; Chinghai Kao; Thomas A. Gardner

Future Innovations in Treating Advanced Prostate Cancer
Urologic Clinics of North America. 2006;33(2):247-272.

2
23.
2006

Juan Antonio Jiménez; Chinghai Kao; Sudhanshu Raikwar; Thomas A. Gardner

Current status of anti-angiogenesis therapy for prostate cancer^{{star, open}}
Urologic Oncology: Seminars and Original Investigations. 2006;24(3):260-268.

15
24.
2006

Xiong Li; Chaeyong Jung; You-Hong Liu; Kyung-Hee Bae; Yan-Ping Zhang; Hong-Ji Zhang; Dale VanderPutten; Meei-Huey Jeng; Thomas A. Gardner; Chinghai Kao

Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis
Journal of Gene Medicine. 2006;8(6):679-689.

12
25.
2005

Wohsing Chen; Roy F. Carlson; Russell Fedewa; Ralf Seip; Narendra T. Sanghvi; Kris A. Dines; Richard Pfile; Michael A. Penna; Thomas A. Gardner

The detection and exclusion of the prostate Neuro-Vascular Bundle (NVB) in automated HIFU treatment planning using a pulsed-wave doppler ultrasound system
AIP Conference Proceedings. 2005;754:23-26.

0
26.
2005

Chandru P. Sundaram; Michael O. Koch; Thomas Gardner; Jonathan E. Bernie

Utility of the fourth arm to facilitate robot-assisted laparoscopic radical prostatectomy
BJU International. 2005;95(1):183-186.

7
27.
2005

Yen-Chuan Ou; Thomas A. Gardner; Chinghaj Kao; Haiyen E. Zhau; Leland W. Chung

A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter
Anticancer Research. 2005;25(2 A):881-886.

3
28.
2005

C. Jung; R.-S. Kim; H. Zhang; S.-J. Lee; H. Sheng; P.J. Loehrer; T.A. Gardner; M.-H. Jeng; C. Kao

HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
British Journal of Cancer. 2005;92(12):2233-2239.

18
29.
2005

Sandra A. Armatys; Michael O. Koch; Richard Bihrle; Thomas A. Gardner; Liang Cheng

Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?
BJU International. 2005;96(6):777-780.

15
30.
2005

Bahaa S. Malaeb; Thomas A. Gardner; Vitaly Margulis; Ling Yang; Jay Y. Gillenwater; Leland W. K. Chung; Gail Macik; Kenneth S. Koeneman

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants
Urology. 2005;66(4):830-834.

6
31.
2005

Jonathan E Bernie; Ramakrishna Venkatesh; James Brown; Thomas A Gardner; Chandru P Sundaram

Comparison of laparoscopic pyeloplasty with and without robotic assistance.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 2005;9(3):258-261.

16
32.
2005

Sandra A. Armatys; Liang Cheng; Thomas A. Gardner; Chandru P. Sundaram

Pulmonary sequestration presenting as retroperitoneal cyst: Case report
Journal of Endourology. 2005;19(8):997-999.

1
33.
2005

Jonathan E. Bernie; James Ng; Vladislav Bargman; Thomas Gardner; Liang Cheng; Chandru P. Sundaram

Evaluation of hydrogel tissue sealant in porcine laparoscopic partial-nephrectomy model
Journal of Endourology. 2005;19(9):1122-1126.

14
34.
2005

Sudhanshu P. Raikwar; Constance J. Temm; Nandita S. Raikwar; Chinghai Kao; Bruce A. Molitoris; Thomas A. Gardner

Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: Enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model
Molecular Therapy. 2005;12(6):1091-1100.

27
35.
2005

Xiong Li; Jie Zhang; Huanling Gao; Edyta Vieth; Kyung-Hee Bae; Yan-Ping Zhang; Sang-Jin Lee; Sudhanshu Raikwar; Thomas A. Gardner; Gary D. Hutchins; et al.

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter
Molecular Cancer Therapeutics. 2005;4(12):1850-1859.

10
36.
2005

Thomas A. Gardner; Michael O. Koch

Prostate cancer therapy with high-intensity focused ultrasound
Clinical Genitourinary Cancer. 2005;4(3):187-192.

12
37.
2005

Ji-Quan Wang; Xiangshu Fei; Thomas A. Gardner; Gary D. Hutchins; Qi-Huang Zheng

Synthesis of 2-amino-6-(4-[ ¹¹C]methoxyphenylthio)-9-[2- (phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester as a novel potential PET gene reporter probe for HBV and HSV-tk in cancers
Bioorganic and Medicinal Chemistry. 2005;13(2):549-556.

13
38.
2005

Michael O. Koch; Thomas A. Gardner

Thermal-based treatment options for localized prostate cancer
Current Treatment Options in Oncology. 2005;6(5):379-387.

3
39.
2005

Liang Cheng; Michael O. Koch; Beth E. Juliar; Joanne K. Daggy; Richard S. Foster; Richard Bihrle; Thomas A. Gardner

The combined percentage of gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy
Journal of Clinical Oncology. 2005;23(13):2911-2917.

44
40.
2005

Xiong Li; Yan-Ping Zhang; Hong-Sup Kim; Kyung-Hee Bae; Keith M. Stantz; Sang-Jin Lee; Chaeyong Jung; Juan A. Jiménez; Thomas A. Gardner; Meei-Huey Jeng; et al.

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer
Cancer Research. 2005;65(5):1941-1951.

38
41.
2004

Ralf Seip; Roy F. Carlson; Wohsing Chen; Narendra T. Sanghvi; Michael A. Penna; Kris A. Dines; Richard Pfile; Thomas A. Gardner; Michael Koch

Automated HIFU treatment planning and execution based on 3D modeling of the prostate, urethra, and rectal wall
Proceedings - IEEE Ultrasonics Symposium. 2004;3:1781-1784.

1
42.
2004

Qi-Huang Zheng; Ji-Quan Wang; Xuan Liu; Xiangshu Fei; Bruce H. Mock; Barbara E. Glick-Wilson; Michael L. Sullivan; Sudhanshu P. Raikwar; Thomas A. Gardner; Chinghai Kao; et al.

An Improved Total Synthesis of PET HSV-tk Gene Reporter Probe 9-(4-[ ¹⁸F]Fluoro-3-hydroxymethylbutyl)guanine ([¹⁸F]FHBG)
Synthetic Communications. 2004;34(4):689-704.

7
43.
2004

Liang Cheng; Gregory T. MacLennan; Chong-Xian Pan; Timothy D. Jones; Curtiss R. Moore; Shaobo Zhang; Jian Gu; Namrata B. Patel; Chinghai Kao; Thomas A. Gardner

Allelic Loss of the Active X Chromosome during Bladder Carcinogenesis
Archives of Pathology and Laboratory Medicine. 2004;128(2):187-190.

14
44.
2004

Ji-Quan Wang; Qi-Huang Zheng; Xiangshu Fei; Xuan Liu; Thomas A. Gardner; Chinghai Kao; Sudhanshu P. Raikwar; Barbara E. Glick-Wilson; Michael L. Sullivan; Bruce H. Mock; et al.

An Improved Total Synthesis of PET HSV-tk Gene Expression Imaging Agent 9-[(3-[¹⁸F]Fluoro-1-hydroxy-2-propoxy)methyl]guanine ([ ¹⁸F]FHPG)
Synthetic Communications. 2004;34(5):917-932.

7
45.
2004

Chia-Ling Hsieh; Thomas A. Gardner; Li Miao; Gary Balian; Leland W.K. Chung

Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells
Cancer Gene Therapy. 2004;11(2):148-155.

27
46.
2004

Qi-Huang Zheng; Thomas A. Gardner; Sudhanshu Raikwar; Chinghai Kao; K. Lee Stone; Tanya D. Martinez; Bruce H. Mock; Xiangshu Fei; Ji-Quan Wang; Gary D. Hutchins

[¹¹C]Choline as a PET biomarker for assessment of prostate cancer tumor models
Bioorganic and Medicinal Chemistry. 2004;12(11):2887-2893.

35
47.
2004

Toshiro Shirakawa; Akinobu Gotoh; Zhujun Zhang; Chinghai Kao; Leland W K Chung; Thomas A Gardner

Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Urology. 2004;63(3):613-618.

1
48.
2004

Heng Hong; Chinghai Kao; Meei-Huey Jeng; John N. Eble; Michael O. Koch; Thomas A. Gardner; Shaobo Zhang; Lang Li; Chong-Xian Pan; Zhiqiang Hu; et al.

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status
Cancer. 2004;101(1):83-89.

71
49.
2004

Ho Yeong Lim; Miwon Ahn; Hyun Cheol Chung; Thomas A. Gardner; Chinghai Kao; Sang-Jin Lee; Se Joong Kim

Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus
Cancer Gene Therapy. 2004;11(8):532-538.

10
50.
2004

Liang Cheng; Shaobo Zhang; Christopher J. Sweeney; Chinghai Kao; Thomas A. Gardner; John N. Eble

Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model
Anticancer Research. 2004;24(4):2135-2140.

19
51.
2004

Trevor M. Soergel; Mark P. Cain; Rosalia Misseri; Thomas A. Gardner; Michael O. Koch; Richard C. Rink; William Strand; Paul Austin; Linda Shortliffe; David Diamond; et al.

Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder
Journal of Urology. 2004;172(4 II):1649-1652.

78
52.
2004

Sang-Jin Lee; Yanping Zhang; Sang Don Lee; Chaeyong Jung; Xiong Li; Hong-Sup Kim; Kyung-Hee Bae; Meei-Huey Jeng; Chinghai Kao; Thomas Gardner

Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer
Molecular Therapy. 2004;10(6):1051-1058.

12
53.
2004

Christopher Sweeney; Lang Li; Rajasubramaniam Shanmugam; Poornima Bhat-Nakshatri; Vetrichelvan Jayaprakasan; Lee Ann Baldridge; Thomas Gardner; Martin Smith; Harikrishna Nakshatri; Liang Cheng

Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
Clinical Cancer Research. 2004;10(16):5501-5507.

100
54.
2003

Guangyuan Zeng; Zhiqiang Hu; Michael S. Kinch; Chong-Xian Pan; David A. Flockhart; Chinghai Kao; Thomas A. Gardner; Shaobo Zhang; Lang Li; Lee Ann Baldridge; et al.

High-Level Expression of EphA2 Receptor Tyrosine Kinase in Prostatic Intraepithelial Neoplasia
American Journal of Pathology. 2003;163(6):2271-2276.

64
55.
2003

Ryan F. Paterson; Eric Barret; Tibério M. Siqueira Jr.; Thomas A. Gardner; Jahangir Tavakkoli; Victor V. Rao; Narendra T. Sanghvi; Liang Cheng; Arieh L. Shalhav

Laparoscopic partial kidney ablation with high intensity focused ultrasound
Journal of Urology. 2003;169(1):347-351.

38
56.
2003

Heng Hong; Michael O. Koch; Richard S. Foster; Richard Bihrle; Thomas A. Gardner; Joanne Fyffe; Thomas M. Ulbright; John N. Eble; Liang Cheng

Anatomic distribution of periprostatic adipose tissue: A mapping study of 100 radical prostatectomy specimens
Cancer. 2003;97(7):1639-1643.

30
57.
2003

Hiroyuki Kubo; Thomas A. Gardner; Yoshitaka Wada; Kenneth S. Koeneman; Akinobu Gotoh; Ling Yang; Chinghai Kao; So Dug Lim; Mahul B. Amin; Hua Yang; et al.

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer
Human Gene Therapy. 2003;14(3):227-241.

82
58.
2003

D.W. Brandli; M.O. Koch; R.S. Foster; R. Bihrle; T.A. Gardner; D. Greene; S.F. Brewster

Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy
BJU International. 2003;92(1):19-23.

20
59.
2003

Michael O. Koch; Anish H. Nayee; James Sloan; Thomas Gardner; Greg R. Wahle; Richard Bihrle; Richard S. Foster

Early catheter removal after radical retropubic prostatectomy: Long-term followup
Journal of Urology. 2003;169(6):2170-2172.

26
60.
2003

Sang-Jin Lee; KangRyul Lee; Xiumei Yang; Chaeyong Jung; Thomas Gardner; Hong-Sup Kim; Meei-Huey Jeng; Chinghai Kao

NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen.
Journal of molecular biology. 2003;330(4):749-760.

15
61.
2003

Ashraf Mosharafa; Michael Koch; Arieh Shalhav; Thomas Gardner; Theodore Logan; Richard Bihrle; Richard Foster

Nephrectomy for metastatic renal cell carcinoma: Indiana University experience
Urology. 2003;62(4):636-640.

18
62.
2003

Leland W. K. Chung; Chia-Ling Hsieh; Andrew Law; Shian-Ying Sung; Thomas A. Gardner; Masayuki Egawa; Shigeji Matsubara; Haiyen E. Zhau

New targets for therapy in prostate cancer: Modulation of stromal-epithelial interactions
Urology. 2003;62(5 SUPPL. 1):44-54.

35
63.
2003

Richard Gorlick; Peter Anderson; Irene Andrulis; Carola Arndt; G. Peter Beardsley; Mark Bernstein; Julia Bridge; Nai-Kong Cheung; Jeffrey S. Dome; David Ebb; et al.

Biology of Childhood Osteogenic Sarcoma and Potential Targets for Therapeutic Development: Meeting Summary
Clinical Cancer Research. 2003;9(15):5442-5453.

76
64.
2002

Toyoaki Uchida; Narendra T. Sanghvi; Thomas A. Gardner; Michael O. Koch; Daisuke Ishii; Sadanori Minei; Takefumi Satoh; Toru Hyodo; Akira Irie; Shiro Baba

Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: A preliminary report
Urology. 2002;59(3):394-398.

123
65.
2002

Arieh L. Shalhav; Eric Barret; David A. Lifshitz; Larry H. Stevens; Thomas A. Gardner; James E. Lingeman

Transperitoneal laparoscopic renal surgery using blunt 12-mm trocar without fascial closure
Journal of Endourology. 2002;16(1):43-46.

15
66.
2002

Jun Cheon; Du Geon Moon; Hyun Yee Cho; Hong Seok Park; Je Jong Kim; Thomas A. Gardner; Chinghai Kao

Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model
International Journal of Urology. 2002;9(5):261-267.

4
67.
2002

Thomas A. Gardner; James Sloan; Sudhanshu P. Raikwar; Chinghai Kao

Prostate cancer gene therapy: Past experiences and future promise
Cancer and Metastasis Reviews. 2002;21(2):137-145.

5
68.
2002

Shaobo Zhang; Jian Gu; Ning-Sun Yang; Chinghai Kao; Thomas A. Gardner; John N. Eble; Liang Cheng

Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transfer
Prostate. 2002;51(4):286-292.

7
69.
2002

Arieh L. Shalhav; Tibério M. Siqueira Jr.; Thomas A. Gardner; Ryan F. Paterson; Larry H. Stevens

Manual specimen retrieval without a pneumoperitoneum preserving device for laparoscopic live donor nephrectomy
Journal of Urology. 2002;168(3):941-944.

21
70.
2002

Tibério M Siqueira Jr; Thomas A Gardner; Ramsay L Kuo; Ryan F Paterson; Larry H Stevens; James E Lingeman; Arieh L Shalhav

One versus two proficient laparoscopic surgeons for laparoscopic live donor nephrectomy
Urology. 2002;60(3):406-409.

11
71.
2002

Sang-Jin Lee; Hong-Sup Kim; Rong Yu; KangRyul Lee; Thomas A. Gardner; Chaeyong Jung; Meei-Huey Jeng; Fan Yeung; Liang Cheng; Chinghai Kao

Novel prostate-specific promoter derived from PSA and PSMA enhancers
Molecular Therapy. 2002;6(3):415-421.

49
72.
2002

Tibério M. Siqueira Jr.; Ramsay L. Kuo; Thomas A. Gardner; Ryan F. Paterson; Larry H. Stevens; James E. Lingeman; Michael O. Koch; Arieh L. Shalhav

Major complications in 213 laparoscopic nephrectomy cases: The Indianapolis experience
Journal of Urology. 2002;168(4 I):1361-1365.

56
73.
2002

Ralf Seip; Jahangir Tavakkoli; Roy F. Carlson; Adam Wunderlich; Narendra T. Sanghvi; Kris A. Dines; Thomas A. Gardner

High-intensity focused ultrasound (HIFU) multiple lesion imaging: Comparison of detection algorithms for real-time treatment control
Proceedings of the IEEE Ultrasonics Symposium. 2002;2:1427-1430.

5
74.
2002

Jiazhong Jiang; Thomas M. Ulbright; Shaobo Zhang; George J. Eckert; Chinghai Kao; Thomas A. Gardner; Michael O. Koch; John N. Eble; Liang Cheng

Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma
Cancer. 2002;95(2):296-300.

26
75.
2002

Shaobo Zhang; Guangyuan Zeng; Chinghai Kao; Thomas Gardner; Christopher Sweeney; Ning-Sun Yang; John N. Eble; Liang Cheng

Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system
Prostate. 2002;53(1):69-76.

8
76.
2002

Thomas A. Gardner; Michael O. Koch; Arieh Shalhav; Richard Bihrle; R. Foster; Christopher Steidle; Ivan Grunberger; Allen Seftel; Martin Resnick; James Cochran; et al.

Minimally invasive treatment of benign prostatic hyperplasia with high intensity focused ultrasound using the Sonablate™ system: An updated report of phase III clinical studies conducted in the USA
Proceedings of SPIE - The International Society for Optical Engineering. 2002;4609:107-114.

4
77.
2001

T.A. Gardner; S.-C. Ko; L. Yang; J.J.S. Cadwell; L.W.K. Chung; C. Kao

Serum-free recombinant production of adenovirus using a hollow fiber capillary system
BioTechniques. 2001;30(2):422-427.

9
78.
2001

Trevor M. Soergel; Michael O. Koch; Richard S. Foster; Richard Bihrle; Gregory Wahle; Thomas Gardner; Sin-Ho Jung

Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy
Journal of Urology. 2001;166(6):2198-2201.

17
79.
2001

S. Matsubara; Y. Wada; T.A. Gardner; M. Egawa; M.-S. Par; C.-L. Hsieh; H.E. Zhau; C. Kao; S. Kamidono; J.Y. Gillenwater; et al.

A conditional replication-competent adenoviral vector, AD-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis
Cancer Research. 2001;61(16):6012-6019.

119
80.
2001

Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang; Kazuro Sugimura; Masafumi Matsuo; Sadao Kamidono; Akinobu Gotoh

Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
International Journal of Cancer. 2001;94(2):282-289.

14
81.
2000

T. Shirakawa; A. Gotoh; Y. Wada; S. Kamidono; S.-C. Ko; C. Kao; T.A. Gardner; L.W.K. Chung

Tissue-specific promoters in gene therapy for the treatment of prostate cancer
Molecular Urology. 2000;4(2):73-82.

20
82.
2000

Kenneth S. Koeneman; Chinghai Kao; Song-Chu Ko; Ling Yang; Yoshitaka Wada; David F. Kallmes; Jay Y. Gillenwater; Haiyen E. Zhau; Leland W. K. Cluing; Thomas A. Gardner

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
World Journal of Urology. 2000;18(2):102-110.

94
83.
2000

Toshiro Shirakawa; Akinobu Gotoh; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang; Shigeji Matsubara; Yoshitaka Wada; Nobuyuki Hinata; Masato Fujisawa; Keisuke Hanioka; et al.

P53 Adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model
Journal of Gene Medicine. 2000;2(6):426-432.

4
84.
2000

Ralf Seip; Mihir Biswas; Maksim Kuznetsov; Narendra T. Sanghvi; Thomas A. Gardner; Noshir F. Dabhoiwala

Transurethral high intensity focused ultrasound: Catheter based prototypes and experimental results
Proceedings of the IEEE Ultrasonics Symposium. 2000;2:1413-1416.

3
85.
2000

Thomas A. Gardner; Eric A. Bissonette; Gina R. Petroni; Rebecca McClain; Mitchell H. Sokoloff; Dan Theodorescu

Surgical postoperative factors affecting length of hospital stay after radical prostatectomy
Cancer. 2000;89(2):424-430.

32
86.
1999

Toshiro Shirakawa; Thomas A. Gardner; Song-Chu Ko; Neil Bander; Savio Woo; Akinobu Gotoh; Sadao Kamidono; Leland W. K. Chung; Chinghai Kao

Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5- fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model
Journal of Urology. 1999;162(3 I):949-954.

25
87.
1999

Jimmy S.J. Wu; Narendra T. Sanghvi; Michael H. Phillips; M. Kuznetsov; R.S. Foster; R. Bihrle; T.A. Gardner; S.I. Umemura

Experimental studies of using of split beam transducer for prostate cancer therapy in comparison to single beam transducer
Proceedings of the IEEE Ultrasonics Symposium. 1999;2:1443-1446.

7
88.
1998

T.A. Gardner; M. Ostad; D.T. Mininberg

Diagnostic flexible peritoneoscopy: Assessment of the contralateral internal inguinal ring during unilateral herniorrhaphy
Journal of Pediatric Surgery. 1998;33(10):1486-1489.

7
89.
1998

C.P. Pavlovich; G.A. Gmyrek; T.A. Gardner; D.P. Poppas; D.T. Mininberg

Flexible transinguinal laparoscopy to assess the contralateral ring in pediatric inguinal hernias
Techniques in Urology. 1998;4(3):141-144.

2
90.
1998

T.A. Gardner; M.L. Lemer; P.N. Schlegel; R.S. Waldbaum; E. Darracott Vaughan Jr.; J. Steckel

Microfocal prostate cancer: Biopsy cancer volume does not predict actual tumour volume
British Journal of Urology. 1998;81(6):839-843.

27
91.
1998

Toshiro Shirakawa; Song-Chu Ko; Thomas A. Gardner; Jun Cheon; Tadayuki Miyamoto; Akinobu Gotoh; Leland W. K. Chung; Chinghai Kao

In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy
Cancer Gene Therapy. 1998;5(5):274-280.

40
92.
1998

Akinobu Gotoh; Song-Chu Ko; Toshiro Shirakawa; Jun Cheon; Chinghai Kao; Tadayuki Miyamoto; Thomas A. Gardner; Ling-Jun Ho; Catharina B. J. Cleutjens; Jan Trapman; et al.

Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
Journal of Urology. 1998;160(1):220-229.

85
93.
1997

Jun Cheon; Song-Chu Ko; Thomas A. Gardner; Toshiro Shirakawa; Akinobu Gotoh; Chinghai Kao; Leland W.K. Chung

Chemogene therapy: Osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a marine osteosarcoma model
Cancer Gene Therapy. 1997;4(6):359-365.

45
94.
1996

Gerald J. Matthews; Thomas A. Gardner; J. Francois Eid

In vitro fertilization improves pregnancy rates for sperm obtained by rectal probe ejaculation
Journal of Urology. 1996;155(6):1934-1937.

16
95.
1994

T.A. Gardner; D.P. Poppas; J.T. Wei; J.G. Blaivas

Volvulus of the ileal conduit: A late complication
Journal of Urology. 1994;152(3):948-950.

5
96.
1994

S. Ngadiman; S.A. Hoda; W.G. Campbell; T. Gardner; M. May

Concurrent malakoplakla and primary squamous cell carcinoma arising in long-standing chronic cystitis
British Journal of Urology. 1994;74(6):801-802.

3

Thomas A. Gardner School of Medicine, Urology

Thomas A. Gardner

96 Publications

Thomas A. Gardner
School of Medicine, Urology